Avestria Ventures is a venture capital firm specializing in early-stage investments in women's health and female-led life science ventures. The company focuses on overlooked and undervalued markets, leveraging technology and data to enhance healthcare quality, access, and affordability. Avestria aims to empower patients and drive clinical or behavioral change through evidence-based businesses with scalable commercialization plans.
Recent Transactions involving Avestria Ventures
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing |
GeneMatters |
Genome Medical |
Casdin CapitalGVIllumina VenturesLRVHealthEcho Health VenturesRevelation PartnersHealthInvest Equity PartnersAvestria VenturesFlywheel VenturesDreamers FundBlue Ivy VenturesAmgen VenturesCanaan PartnersKaiser Permanente VenturesPerceptive Advisors |
Medical Practices |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →